Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney E Wegner

Showing results (61-70 of 154) with videos related to

Pageof 16
Sort By:
Advances in Radiation Oncology|April 3, 2024
Cost of Treatment for Brain Metastases Using Data From a National Health InsuranceJoseph Crooks, Oralia Dominic, Matthew Shepard, et al.
Journal of Neurosurgery. Case Lessons|April 14, 2025
Diffuse glioneuronal tumor in Lynch syndrome: illustrative caseStephen Jaffee, Trent Kite, Kymberly Gyure, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2011
Stereotactic radiosurgery for patients with brain metastases from small cell lung cancerRodney E Wegner, Adam C Olson, Douglas Kondziolka, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Re-irradiation strategies for head-and-neck cancers: implications for stereotactic body radiotherapy: in regard to Chen et al (Int J Radiant Oncol Biol Phys 2011;81:1211-1219)John A Vargo, Dwight E Heron, Robert L Ferris, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<sub>10</sub> enough?Stephen Abel, Shaakir Hasan, Vivek Verma, et al.
Radiation Oncology Journal|January 12, 2019
Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysisRodney E Wegner, Stephen Abel, Richard J White, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The role of adjuvant therapy for atypical bronchopulmonary carcinoidsRodney E Wegner, Stephen Abel, Shaakir Hasan, et al.
Journal of Gastrointestinal Cancer|September 6, 2021
Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB ReviewRobin R Rodriguez, Stephen Abel, Jyothika Mamadgi, et al.
Technology in Cancer Research & Treatment|February 17, 2012
Comparison of whole versus partial vertebral body stereotactic body radiation therapy for spinal metastasesVeeral B Patel, Rodney E Wegner, Dwight E Heron, et al.
Cancer Medicine|August 9, 2024
The survival outcomes of localized low-risk prostate cancer, a population-based study using NCDBShifeng Mao, Arash Samiei, Yue Yin, et al.
Pageof 16

Showing results (61-70 of 154) with videos related to

Sort By:
Pageof 16
Advances in Radiation Oncology|April 3, 2024
Cost of Treatment for Brain Metastases Using Data From a National Health InsuranceJoseph Crooks, Oralia Dominic, Matthew Shepard, et al.
Journal of Neurosurgery. Case Lessons|April 14, 2025
Diffuse glioneuronal tumor in Lynch syndrome: illustrative caseStephen Jaffee, Trent Kite, Kymberly Gyure, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2011
Stereotactic radiosurgery for patients with brain metastases from small cell lung cancerRodney E Wegner, Adam C Olson, Douglas Kondziolka, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2012
Re-irradiation strategies for head-and-neck cancers: implications for stereotactic body radiotherapy: in regard to Chen et al (Int J Radiant Oncol Biol Phys 2011;81:1211-1219)John A Vargo, Dwight E Heron, Robert L Ferris, et al.
Lung Cancer (Amsterdam, Netherlands)|August 27, 2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<sub>10</sub> enough?Stephen Abel, Shaakir Hasan, Vivek Verma, et al.
Radiation Oncology Journal|January 12, 2019
Trends in intensity-modulated radiation therapy use for rectal cancer in the neoadjuvant setting: a National Cancer Database analysisRodney E Wegner, Stephen Abel, Richard J White, et al.
Lung Cancer (Amsterdam, Netherlands)|April 28, 2019
The role of adjuvant therapy for atypical bronchopulmonary carcinoidsRodney E Wegner, Stephen Abel, Shaakir Hasan, et al.
Journal of Gastrointestinal Cancer|September 6, 2021
Analysis of Post-operative Adjuvant Chemotherapy Versus Adjuvant Chemoradiation Therapy Outcomes in Non-metastatic Cholangiocarcinoma: an NCDB ReviewRobin R Rodriguez, Stephen Abel, Jyothika Mamadgi, et al.
Technology in Cancer Research & Treatment|February 17, 2012
Comparison of whole versus partial vertebral body stereotactic body radiation therapy for spinal metastasesVeeral B Patel, Rodney E Wegner, Dwight E Heron, et al.
Cancer Medicine|August 9, 2024
The survival outcomes of localized low-risk prostate cancer, a population-based study using NCDBShifeng Mao, Arash Samiei, Yue Yin, et al.
Pageof 16